期刊文献+

牙釉质细胞型颅咽管瘤基因表达的基因芯片研究

Study of Gene Expression Profile of Adamantinomatous Craniopharyngiomas by cDNA Microarray
下载PDF
导出
摘要 目的建立牙釉质细胞型颅咽管瘤的基因表达谱,筛选差异表达基因,并探讨其与牙釉质细胞型颅咽管瘤的关系。方法采用cDNA微阵列分析牙釉质细胞型颅咽管瘤组织与正常垂体柄组织基因表达谱的变化,应用实时荧光定量PCR技术验证cDNA微阵列检测出差异基因的可靠性,分析牙釉质细胞型颅咽管瘤组织相关基因的差异表达。结果发现釉质细胞型颅咽管瘤与正常垂体组织之间差异性表达基因453条,其中前者表达下调258条,表达下调195条。结论牙釉质细胞型颅咽管瘤的发生可能涉及到细胞转录、细胞增殖、细胞凋亡等诸多方面,其相关基因表达的变化及其临床和病理学意义尚需进一步验证。 Objectives To establish the gene expression profile of adamantinomatous craniopharyngiomas and investigate the expression of the differential gene related to adamantinomatous craniopharyngio'nas. Methods The difference in the gene expression profile between adamantinomatous craniopharyngiomas and normal tissue of hypophyseal stalk were analyzed by cDNA microarray which contained approximately 16 450 unigene that would be tested in the study. Real-time quantitative PCR technique was employed to validate the authenticity of cDNA microarray. Results Four hundred and fifty-three genes expressed in adamantinomatous cranio-pharyngiomas were different from the gene expressed in the normal hypophyseal stalk. Of these 453 genes, 195 genes were upregulated and 258 were down-regulated in the adamantinomatous craniopharyngiomas compared to those in the normal hypophyseal stalk. Conclusions It is suggested that several genes are involved in the pathogenesis of adamantinomatous craniopharyngiomas. However, their relationship with the pathogenesis of adamantinomatous craniopharyngiomas should be studied further.
出处 《中国临床神经外科杂志》 2008年第12期708-711,共4页 Chinese Journal of Clinical Neurosurgery
基金 江西省自然科学基金资助项目(0440057)
关键词 牙釉质细胞型颅咽管瘤 基因表达谱 CDNA微阵列 Adamantinomatous craniopharyngiomas Gene expression profile cDNA microarray
  • 相关文献

参考文献10

  • 1Kim SK, Wang KC, Shin SH, et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors [J]. Child's Nerv Syst, 2001, 17(9): 531-537.
  • 2Bruni P, Minopoli G, Brancaccio T, et al. Fe65, a ligand of he Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression [J]. J Biol Chem, 2002, 277(38): 35481-35488.
  • 3Tzachanis D, Freeman GJ, Hirano N, et al . Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells [J]. Nat Immunol, 2001, 2(12): 1174-1182.
  • 4Tanaka K, Nigg EA. Cloning and characterization of the murine Nek3 protein kinase, a novel member of the NIMA family of putative cell cycle regulators [J]. J Biol Chem, 1999, 274(19): 13491-13497.
  • 5黄秀兰,崔国辉,周克元.PI3K-Akt信号通路与肿瘤细胞凋亡关系的研究进展[J].癌症,2008,27(3):331-336. 被引量:119
  • 6Breitschopf K, Haendeler J, Malchow P, et al . Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway [J]. Mol Cell Biol, 2000, 20(5): 1886-1896.
  • 7Seeberger KL, Dufour JM, Shapiro AM, et ol . Expansion of mesenchymal stem cells from human pancreatic ductal epithelium [J]. Lab Invest, 2006, 86(2): 141-153.
  • 8Yamamoto M, Kiyota T, Walsh SM, et al . Kinetic analysis of aggregated amyloid-beta peptide clearance in adult bone -marrow-derived macrophages from APP and CCL2 transgenic mice [J]. J Neuroimmune Pharmacol, 2007, 2 (2): 213-221.
  • 9Kelberman D, Dattani MT. Hypothalamic and pituitary development: novel insights into the aetiology [J]. Eur J Endocrinol, 2007, 157 (Suppl 1):S3-14.
  • 10Setlur SR, Dighe RR. Single chain human chorionic gonadotropin, hCG alpha beta: effects of mutations in the alpha subunit on structure and bioactivity [J]. Glycoconj J, 2007, 24(1): 97-106.

二级参考文献58

  • 1康春生,浦佩玉,李捷,王广秀.反义及显性负调节AKT2 RNA对脑胶质瘤细胞增殖抑制作用的体外研究[J].癌症,2004,23(11):1267-1272. 被引量:5
  • 2王宏梅,陈龙华,郑小康,李启生,伍新尧,夏云飞.抑制ATM/PI3K功能区表达对鼻咽癌细胞CNE1辐射增敏的研究[J].癌症,2006,25(9):1097-1101. 被引量:9
  • 3Atkins M B, Hidalgo M, Stadler W M, et al. Randomized phase Ⅱ study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma [J]. J Clin Oncol, 2004, 22(5) :909-918.
  • 4Christian T, James R, Zoran F, et al. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer : implications for therapy [ J ]. Proc Natl Acad Sci USA, 2006,103 (6) : 1888-1893.
  • 5Adachi S, Leoni L M, Carson D A, et al. Apoptosis induced by molecular targeting therapy in hematological malignancies [J]. Acta Haematol, 2004,111(1-2) : 107-123.
  • 6Campiglio M, Olgiati C, Normanno N, et al. Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 ( 'Iressa' ) is independent of EGFR expression level [J]. J Cell Physiol, 2004,198(2): 259-268.
  • 7Zhang M, Fang X, Liu H, et al. Blockade of AKT activation in prostate cancer cells with a small molecule inhibitor, 9-chIoro-2-methylellipticinium acetate (CMEP) [J]. Biochem Pharmacol, 2007,73( 1 ) : 15-24.
  • 8Douglas A L, Faina B, Cindy J Y, et al. Frequent mutation of the P1K3CA gene in ovarian and breast cancer [J]. Clin Cancer Res, 2005,11 (8):2875- 2878.
  • 9Knobbe C B, Kieslich A T, Reifenberger G. Genetic alteration and expression of the phosphoinositol-3- kinase/Akt pathway genes P1K3CA and PIKE in human glioblastomas [J]. Neuropathol Appl Neurobiol, 2005, 31 (5) :486-490.
  • 10Oda K, Stokoe D, Taketani Y, et al. High frequency of coexistent mutations of P1K3CA and PTEN genes in endometrial carcinoma [ R ]. Cancer Res, 2005,65(23) : 10669-10673.

共引文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部